Celebrating Clinical Trial Participants: Citizen Scientists®
The Global Alzheimer's Platform Foundation (GAP) created a first-of-its kind award to celebrate Alzheimer's and Parkinson's disease clinical trial participants. The only way to find treatments and cures for these diseases are through clinical trials, and the volunteers that make the research possible.
The Need for More Clinical Trial Participants is Significant
Alzheimer's and Parkinson's trials over the next few years are estimated to need more than 25,000 participants. According to a 2016 Harris Poll undertaken by GAP, 60% of Americans are willing, or would consider, participating in an Alzheimer's and Parkinson's disease clinical trial. However, less than 10% of people do. There is a systemic need to educate North Americans about the availability of clinical trials and encourage participation.